Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cellectar Biosciences, Inc. - Common Stock (NQ: CLRB ) 0.2535 -0.0222 (-8.05%) Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 800,426 Open 0.2700 Bid (Size) 0.2614 (2) Ask (Size) 0.2696 (4) Prev. Close 0.2757 Today's Range 0.2520 - 0.2752 52wk Range 0.2240 - 4.450 Shares Outstanding 40,566,534 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 11, 2024 Via Benzinga Crude Oil Jumps 2%; Macy's Lowers Earnings Forecast December 11, 2024 Via Benzinga Exposures Fossil Fuels Performance YTD -91.14% -91.14% 1 Month -83.85% -83.85% 3 Month -87.33% -87.33% 6 Month -90.61% -90.61% 1 Year -90.29% -90.29% More News Read More Cellectar Biosciences Stock Plunges As Cancer-Focused Cancer Firm Pursues Strategic Options December 11, 2024 Via Benzinga Exposures Product Safety Nasdaq Surges Over 1%; US Inflation Rises In-Line With Expectations December 11, 2024 Via Benzinga Topics Economy Exposures Interest Rates Why Stitch Fix Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket December 11, 2024 Via Benzinga Earnings Preview For Cellectar Biosciences March 26, 2024 Via Benzinga Cellectar Biosciences Provides Strategic Update on Clinical Development, Pipeline Programs and Corporate Restructuring December 10, 2024 From Cellectar Biosciences, Inc. Via GlobeNewswire Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update November 18, 2024 From Cellectar Biosciences, Inc. Via GlobeNewswire Earnings Scheduled For November 18, 2024 November 18, 2024 Via Benzinga Cellectar Biosciences and NorthStar Medical Radioisotopes Announce Partnership for Supply of Actinium-225 November 14, 2024 From Cellectar Biosciences, Inc. Via GlobeNewswire Cellectar Biosciences and SpectronRx Partner to Manufacture Novel Phospholipid Radioconjugate for the Treatment of Cancer November 12, 2024 From Cellectar Biosciences, Inc. Via GlobeNewswire Gold Moves Higher; Coca-Cola Increases FY24 Forecast July 23, 2024 Via Benzinga Crude Oil Down 2%; GE Aerospace Earnings Top Views July 23, 2024 Via Benzinga Exposures Fossil Fuels Cancer-Focused Cellectar Biosciences Stock Trades Lower Despite Meeting Goal In Blood Cancer Study July 23, 2024 Via Benzinga Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 23, 2024 Via Benzinga CLRB Stock Earnings: Cellectar Biosciences Misses EPS for Q1 2024 May 14, 2024 Via InvestorPlace Hedgeye Warns That Reddit (RDDT) Stock Will Fall 50% March 27, 2024 Via InvestorPlace Why Is Gamida Cell (GMDA) Stock Down 82% Today? March 27, 2024 Via InvestorPlace CLRB Stock Earnings: Cellectar Biosciences Beats EPS for Q4 2023 March 27, 2024 Via InvestorPlace Earnings Scheduled For March 27, 2024 March 27, 2024 Via Benzinga Cellectar Biosciences Is An 'Attractive Acquisition Target' According To This Analyst - Here's Why March 04, 2024 Via Benzinga Why Is Cancer-Focused Cellectar Biosciences Stock Trading Higher Today? January 08, 2024 Via Benzinga Wells Fargo Is Warming Up to Enphase Energy (ENPH) Stock January 08, 2024 Via InvestorPlace Why Is Spirit AeroSystems (SPR) Stock Down 14% Today? January 08, 2024 Via InvestorPlace Why Is LumiraDx (LMDX) Stock Down 13% Today? January 08, 2024 Via InvestorPlace Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
